Evidence map›Paper›PMID 39613910›Full record

ArticleEuropean journal of human genetics : EJHG2025

Evaluating an approach for communicating integrated risk scores for melanoma.

Courtney K Wallingford, Adam Mothershaw, Clare Primiero, Tenielle Clinch, Tamara Dawson, Nathan Ingold, H Peter Soyer, Matthew H Law, Aideen McInerney-Leo, Tatiane Yanes

Abstract read
In one paragraph

Article in European journal of human genetics : EJHG, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Courtney K WallingfordFrazer Institute, The University of Queensland, Dermatology Research Centre, Brisbane, QLD, Australia.
Adam MothershawFrazer Institute, The University of Queensland, Dermatology Research Centre, Brisbane, QLD, Australia.ORCID 0000-0002-0056-8187
Clare PrimieroFrazer Institute, The University of Queensland, Dermatology Research Centre, Brisbane, QLD, Australia.
Tenielle ClinchFrazer Institute, The University of Queensland, Dermatology Research Centre, Brisbane, QLD, Australia.ORCID 0009-0000-6122-3062
Tamara DawsonMelanoma and Skin Cancer Advocacy Network, Melbourne, VIC, Australia.
Nathan IngoldStatistical Genetics, QIMR Berghofer Medical Research Institute, 300 Herston Rd, Herston, QLD, 4006, Australia.
H Peter SoyerFrazer Institute, The University of Queensland, Dermatology Research Centre, Brisbane, QLD, Australia.
Matthew H LawMelanoma and Skin Cancer Advocacy Network, Melbourne, VIC, Australia.
Aideen McInerney-LeoFrazer Institute, The University of Queensland, Dermatology Research Centre, Brisbane, QLD, Australia.ORCID 0000-0002-0059-5732
Tatiane YanesFrazer Institute, The University of Queensland, Dermatology Research Centre, Brisbane, QLD, Australia. t.yanes@uq.edu.au.ORCID 0000-0002-3905-3025

Funding

Department of Health | National Health and Medical Research Council (NHMRC) APP1137127Department of Health | National Health and Medical Research Council (NHMRC) APP2009136
6 · The paper itself

Abstract

Integrated risk scores (polygenic and non-genetic risk factors) can facilitate risk-stratification, to inform targeted melanoma screening. This mixed-methods pilot study assessed satisfaction, attitudes, and psychosocial impact of a protocol for communicating integrated risk for melanoma using questionnaires (baseline and 1-month post-results) and semi-structured interviews. Affected and unaffected adults enroled in ongoing melanoma studies were recruited to receive their integrated risk booklets and attend a genetic counselling appointment. 35/73 consented to participate; 31 and 33 completed baseline and follow-up questionnaires, respectively. Participants rated the information as useful, felt it motivated favourable health behaviours and were satisfied with the quality and content of the booklet. All participants felt highly empowered managing melanoma risk at baseline and follow-up. Most participants were unsure or felt little to no control over preventing future melanomas, which did not change at follow-up (Chi-square p = 0.73). Genetic-specific distress, and uncertainty was low for all participants post-results. Qualitative interviews supported quantitative findings and highlighted importance of access to a clinician for results interpretation and risk-management. In this high-risk cohort, the communication model was acceptable, and did not result in negative psychosocial sequelae. Findings from this study highlight key considerations for effective communication and delivery of integrated risk which can be used to inform future research in more diverse cohorts for melanoma and other common conditions.

Indexed as

Genetic CounselingGenetic TestingMelanomaSkin NeoplasmsAdultAgedCommunicationFemaleGenetic Predisposition to DiseaseHumansMaleMiddle AgedPilot ProjectsRisk AssessmentRisk FactorsSurveys and Questionnaires

Identifiers

PMID39613910
PMCPMC11985965

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.